Related Experiment Video

Updated: Mar 1, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.8K

miR-30e acts as a tumor suppressor in hepatocellular carcinoma partly via JAK1/STAT3 pathway

Junjie Mao1, Xiaojun Hu1, Pengfei Pang1

  • 1Center for Interventional Medicine, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, Guangdong 519000, P.R. China.

Oncology Reports
|June 1, 2017
PubMed

Insights

MicroRNA-30e (miR-30e) acts as a tumor suppressor in hepatocellular carcinoma (HCC) by inhibiting cell growth and invasion. This study identifies miR-30e as a novel therapeutic target in HCC, potentially improving patient survival.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with unclear diagnostic and therapeutic targets.
  • MicroRNA-30e (miR-30e) shows differential expression in HCC tissues and cell lines, suggesting a potential role.

Purpose of the Study:

  • To investigate the functional roles of miR-30e in hepatocellular carcinoma (HCC) cells.
  • To elucidate the underlying molecular mechanisms and cancer networks modulated by miR-30e.

Main Methods:

  • Quantitative real-time polymerase chain reaction (qRT-PCR) to determine miR-30e expression.
  • Cell proliferation, migration, invasion, and apoptosis assays.
  • Dual-luciferase reporter assays to identify miR-30e targets.
  • Western blotting and small interfering RNA (siRNA) to assess gene silencing.
  • Interleukin-6 (IL-6) treatment to investigate pathway modulation.

Main Results:

  • miR-30e was downregulated in HCC cell lines (HepG2, HuH7).
  • miR-30e mimics suppressed proliferation, migration, and invasion, and promoted apoptosis in HCC cells.
  • JAK1 was identified as a direct target of miR-30e, with miR-30e mimics downregulating JAK1 expression.
  • JAK1 silencing inhibited HCC cell proliferation, migration, and invasion.
  • The JAK1/STAT3 pathway was implicated, as IL-6 partially reversed miR-30e mimic-induced inhibition of cell migration.

Conclusions:

  • miR-30e functions as a tumor suppressor in HCC by targeting JAK1 and modulating the JAK1/STAT3 pathway.
  • miR-30e represents a novel therapeutic target and potential prognostic biomarker for HCC.
  • This study reveals a new mechanism of miRNA-mediated gene regulation in cancer cells.

More Related Videos

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines08:50

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines

Published on: April 18, 2025

1.0K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

9.6K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.9K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K